Cargando…

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis

The number of effective first-line antibiotics for the treatment of Mycobacterium tuberculosis infection is strongly limited to a few drugs. Due to emerging resistance against those drugs, second- and third-line antibiotics have been established in therapy with certain problems and also increasing m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lentz, Fabian, Reiling, Norbert, Martins, Ana, Molnár, Joseph, Hilgeroth, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017859/ https://www.ncbi.nlm.nih.gov/pubmed/29617279 http://dx.doi.org/10.3390/molecules23040825

Ejemplares similares

Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-Tuberculosis (Tb) Activities of Clofazimine
por: Lentz, Fabian, et al.
Publicado: (2019)

Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy
por: Döring, Henry, et al.
Publicado: (2020)

Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis
por: Shekar, Sandhya, et al.
Publicado: (2014)

Novel Isoniazid-Carborane Hybrids Active In Vitro against Mycobacterium tuberculosis
por: Różycka, Daria, et al.
Publicado: (2020)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Two Novel katG Mutations Conferring Isoniazid Resistance in Mycobacterium tuberculosis
por: Hsu, Li-Yu, et al.
Publicado: (2020)

The Wnt Blows: On the Functional Role of Wnt Signaling in Mycobacterium tuberculosis Infection and Beyond
por: Brandenburg, Julius, et al.
Publicado: (2016)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis
por: Gagneux, Sebastien, et al.
Publicado: (2006)

Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2012)

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
por: Lee, Jong-Hee, et al.
Publicado: (2012)

Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid
por: Jaiswal, Indu, et al.
Publicado: (2017)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
por: Hempel, Cornelius, et al.
Publicado: (2017)

Lectins of Mycobacterium tuberculosis – rarely studied proteins
por: Kolbe, Katharina, et al.
Publicado: (2019)

Design, Synthesis, and Evaluation of Novel Δ(2)-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant Mycobacterium tuberculosis Mutant
por: Sarkar, Souvik, et al.
Publicado: (2023)

Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test
por: Choi, Seong Won, et al.
Publicado: (2014)

Nitrite impacts the survival of Mycobacterium tuberculosis in response to isoniazid and hydrogen peroxide
por: Cunningham-Bussel, Amy, et al.
Publicado: (2013)

Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques
Publicado: (2021)

In silico analyses of isoniazid and streptomycin resistance-associated mutations in Mycobacterium tuberculosis
por: Dasoondi, Rushikesh Singh, et al.
Publicado: (2023)

Xanthohumol from Humulus lupulus L. potentiates the killing of Mycobacterium tuberculosis and mitigates liver toxicity by the combination of isoniazid in mouse tuberculosis models
por: Lou, Hai, et al.
Publicado: (2020)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
por: Fischer, Tim, et al.
Publicado: (2017)

Influence of sex on the exposure to isoniazid in patients with pulmonary tuberculosis
por: Rivera, Juan Gonzalo Bardalez, et al.
Publicado: (2023)

An evolutionary functional genomics approach identifies novel candidate regions involved in isoniazid resistance in Mycobacterium tuberculosis
por: Furió, Victoria, et al.
Publicado: (2021)

Binding of activated isoniazid with acetyl-CoA carboxylase from Mycobacterium tuberculosis
por: Unissa, Ameeruddin Nusrath, et al.
Publicado: (2011)

Isoniazid Inhibits the Heme-Based Reactivity of Mycobacterium tuberculosis Truncated Hemoglobin N
por: Ascenzi, Paolo, et al.
Publicado: (2013)

Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review
por: Seifert, Marva, et al.
Publicado: (2015)

Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
por: Zhang, Tingting, et al.
Publicado: (2019)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium Tuberculosis by Droplet Digital PCR
por: Zheng, Yang, et al.
Publicado: (2022)

In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv
por: Dokrungkoon, Thanadon, et al.
Publicado: (2023)

Novel Nonsymmetrical 1,4-Dihydropyridines as Inhibitors of Nonsymmetrical MRP-Efflux Pumps for Anticancer Therapy
por: Kreutzer, David, et al.
Publicado: (2020)

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
por: Toure, A., et al.
Publicado: (2016)

Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis.
por: Shim, T. S., et al.
Publicado: (1997)

Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples
por: Lu, Wei, et al.
Publicado: (2012)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR
por: Sahebi, Leyla, et al.
Publicado: (2016)

Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India
por: Munir, Asma, et al.
Publicado: (2019)

Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
por: Subbian, Selvakumar, et al.
Publicado: (2016)

Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid
por: Tang, Peijun, et al.
Publicado: (2017)

Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates
por: Charan, Ashok Singh, et al.
Publicado: (2020)

The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Mycobacterium tuberculosis
por: Zomorodbakhsh, Shahab, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_04pmshnelvej6a69o28teoujff